Day: February 10, 2023

LexaGene Holdings Announces Results of February 8, 2023 Annual General Meeting

LexaGene Holdings Announces Results of February 8, 2023 Annual General Meeting

BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated multiplex PCR testing, announces the results of its annual general meeting held on February 8, 2023 (the “AGM”). The Company is pleased to report that, at its AGM, the shareholders voted to re-elect Dr. John (Jack) Regan, Tom Slezak, Dr. Janes Sykes, Joseph Caruso, and Stephen Mastrocola, as directors of the Company for the ensuing year. In addition, the shareholders ratified and approved the re-appointment of RSM US LLP, Chartered Professional Accountants, as the Company’s auditor for the ensuing year. The shareholders also ratified and approved certain amendments to the Company’s Omnibus Incentive Plan...

Continue reading

Subsea7 awarded contracts offshore Norway

Subsea7 awarded contracts offshore Norway

Luxembourg – 10 February 2023 – Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of two contracts by Equinor for the Irpa and Verdande field developments, located in the Norwegian Sea. The combined project awards are defined as sizeable1. The two projects will be executed in a consortium between Subsea7 and DeepOcean. The Irpa field development project, located in the Aasta Hansteen area at 1,350 metres water depth, involves a subsea tieback of approximately 80 kilometres to the Aasta Hansteen FPSO. The contract scope includes engineering, transportation and installation of a MEG pipeline, a production riser, umbilical, subsea structures and tie-ins. The Verdande field development project, located in the Nordland Ridge area, involves a subsea tieback to the existing Skuld field and Norne FPSO facilities. The contract...

Continue reading

Interoil receives formal approval to its acquisition in 2020 of participating interests in five concessions in Santa Cruz, Argentina

Interoil receives formal approval to its acquisition in 2020 of participating interests in five concessions in Santa Cruz, Argentina

Oslo, 10 February 2023 Interoil Exploration and Production ASA is pleased to announce that the Government of the Province of Santa Cruz has granted formal authorization to the assignment to the Company of a 8.34% participating interest in and to the exploitation and exploration concessions CA-10 “PALERMO AIKE”, CA-9 “OCÉANO”, CA-6 “CHORRILLOS”, CA-4 “MOY AIKE” and CA-1 “CAMPO BREMEN”. This Government approval has been given by means of Decree 0121/23 of the Province of Santa Cruz, dated January 31, 2023, and published in the Official Gazette of the Province on February 7, 2023. The participating interests in the five aforementioned concessions, all of them located in the Province of Santa Cruz, were acquired by the Company from Roch S.A., an Argentine company, in 2020 (ref. announcement dated 11 January 2020). In addition to holding the...

Continue reading

Oxurion Receives Transparency Notifications

Oxurion Receives Transparency Notifications

Oxurion Receives Transparency Notifications Leuven, BELGIUM, Boston, MA, US – February 10, 2022 – 7.30 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on February 9, 2023 from Negma Group Ltd. indicating that as of February 3, 2023, it held 12,528,163 shares of the then outstanding 466,875,130 shares, and therefore crossed below the threshold (3%) by virtue of disposal of voting securities. See Annex 1 Oxurion received a transparency notification on February 8, 2023 from Negma Group Ltd. indicating that as of February 1, 2023,...

Continue reading

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SALT LAKE CITY, UT, Feb. 10, 2023 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the closing of its public offering of 2,150,000 units, with each unit consisting of one share of its common stock, or one pre-funded warrant to purchase one share of its common stock, one Class C Warrant with each warrant to purchase one share of common stock, and one half of one Class D Warrant with each whole warrant to purchase one share of common stock. Each unit was sold at a public offering price of $5.60. The Class C and Class D Warrants in the units are immediately exercisable at a price of $5.60 per share. The Class C Warrants expire five years from the date of issuance and the Class D Warrants expire three years from the date of...

Continue reading

Genius Brands International Announces 1-for-10 Reverse Stock Split to Maintain Compliance with Nasdaq Continued Listing Requirements

Genius Brands International Announces 1-for-10 Reverse Stock Split to Maintain Compliance with Nasdaq Continued Listing Requirements

BEVERLY HILLS, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — Genius Brands International, Inc. (“Genius Brands” or the “Company”) (Nasdaq: GNUS), a global brand management company that creates and licenses multimedia entertainment content for children, announced today that it will effect a 1-for-10 reverse stock split of its outstanding common stock, which will be effective for trading purposes as of the commencement of trading on February 13, 2023. The reverse stock split was approved by the Board of Directors of the Company in accordance with Nevada law and is intended to increase the per share trading price of the Company’s common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)). The Company’s common stock will continue to trade on the Nasdaq Capital Market...

Continue reading

Fortress Biotech Announces Closing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Fortress Biotech Announces Closing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

MIAMI, Feb. 10, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced the closing of its previously announced registered direct offering and concurrent private placement. The Company issued 16.6 million shares of its common stock in the registered direct offering priced at-the-market under Nasdaq rules. The purchase price of each share was $0.835. Certain directors and officers of the Company participated in the offering and purchased an aggregate amount of approximately $3.3 million of Fortress common stock at the same purchase price of $0.835 per share, which was at a premium to the consolidated closing...

Continue reading

SFL - Invitation to Presentation of Q4 2022 Results

SFL – Invitation to Presentation of Q4 2022 Results

SFL Corporation Ltd. (“SFL” or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the fourth quarter of 2022 on Wednesday, February 15, 2023. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Wednesday, February 15, 2023, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will be available from the Investor Relations section of the Company’s website at www.sflcorp.com on the same day. In order to listen to the conference call and presentation, you may do one of the following:  A: See Live WebcastVisit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to “Webcast”, or access directly via the webcast link below. The webcast with slideshow will be played live from this platform: SFL Q4 2022 Webcast B:...

Continue reading

FHLB Des Moines Announces 2022 Financial Results

FHLB Des Moines Announces 2022 Financial Results

DES MOINES, Iowa, Feb. 10, 2023 (GLOBE NEWSWIRE) — The Federal Home Loan Bank of Des Moines (the Bank) announced today preliminary unaudited financial results and declared a dividend for the fourth quarter of 2022. The Board of Directors approved a fourth quarter 2022 dividend at an annualized rate of 7.75 percent on activity-based stock, an increase of 0.50 percent from the prior quarter, and 3.00 percent on membership stock, unchanged from the prior quarter. Dividend payments totaling $96 million are expected to be paid on February 17, 2023. The increased dividend rate on activity-based stock is a result of changes in interest rates and business activity. This rate reflects the Bank’s philosophy to pay a consistent dividend equal to or greater than the current market rate for a highly-rated investment, and at a rate that the...

Continue reading

2022 annual results : business performance driven by investment intensification

2022 annual results : business performance driven by investment intensification

Press Release         Ecully, February 10, 2023 – 8:00 pm 2022 annual results: Business growth and investment intensification Continued improvement in gross margin Confirmed Ambitions In thousands of euros Consolidated financial statements 2022 2021 Revenue* 7,432 4,290 Cost of sales (2,320) (1,398) Gross margin % of revenue 5,112 69% 2,892 67% Net operating expenses Of which running costs (8,322) (3,770) (4,301) (1,941) Of which personnel expenses (4,875) (2,479) Operating income/(loss) (3,210) (1,409) Financial income/(expense) 184 223 Non-recurring income/(expenses) (112) (397) Net income/(loss)** (3,137) (1,583) * 2022 revenue includes the share of turnover related to Spine Innovations since its integration on July 21, 2022, i.e. €1.7 million.** Net loss includes the share of net loss related to Spine Innovations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.